Skip to main content
Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
3.330
-0.030 (-0.89%)
At close: Feb 27, 2026, 4:00 PM EST
3.348
+0.018 (0.55%)
After-hours: Feb 27, 2026, 7:50 PM EST

Agenus Revenue

Agenus had revenue of $30.24M in the quarter ending September 30, 2025, with 20.40% growth. This brings the company's revenue in the last twelve months to $106.83M, down -33.41% year-over-year. In the year 2024, Agenus had annual revenue of $103.46M, down -33.81%.

Revenue (ttm)
$106.83M
Revenue Growth
-33.41%
P/S Ratio
1.06
Revenue / Employee
$338,066
Employees
316
Market Cap
113.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024103.46M-52.85M-33.81%
Dec 31, 2023156.31M58.29M59.47%
Dec 31, 202298.02M-197.64M-66.85%
Dec 31, 2021295.67M207.50M235.34%
Dec 31, 202088.17M-61.88M-41.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortress Biotech 62.30M
Seer, Inc. 16.38M
Korro Bio 7.37M
Equillium 4.39M
Coya Therapeutics 3.99M
iBio, Inc. 300.00K
Inovio Pharmaceuticals 182.34K
Revenue Rankings

AGEN News

More News